Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines

H Mehanna; M Evans; M Beasley; S Chatterjee; M Dilkes; J Homer; J O'hara; M Robinson; R Shaw; P Sloan

doi:10.1017/S0022215116000505

Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines

H Mehanna, M Evans, M Beasley, S Chatterjee, M Dilkes, J Homer, J O'hara, M Robinson, R Shaw, P Sloan

Research output: Contribution to journal › Article › peer-review

247 Downloads (Pure)

Abstract

This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. There has been significant debate in the management of oropharyngeal cancer in the last decade, especially in light of the increased incidence, clarity on the role of the human papilloma virus in this disease and the treatment responsiveness of the human papilloma virus positive cancers. This paper discusses the evidence base pertaining to the management of oropharyngeal cancer and provides recommendations on management for this group of patients receiving cancer care.

Original language	English
Pages (from-to)	S90-S96
Journal	The Journal of laryngology and otology
Volume	130
Issue number	S2
Early online date	12 May 2016
DOIs	https://doi.org/10.1017/S0022215116000505
Publication status	E-pub ahead of print - 12 May 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/S0022215116000505Licence: Creative Commons: Attribution (CC BY)

oropharyngeal-cancer-united-kingdom-national-multidisciplinary-guidelinesFinal published version, 131 KBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{b7c08ba7104d469ab1e7b5662443e748,

title = "Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines",

abstract = "This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. There has been significant debate in the management of oropharyngeal cancer in the last decade, especially in light of the increased incidence, clarity on the role of the human papilloma virus in this disease and the treatment responsiveness of the human papilloma virus positive cancers. This paper discusses the evidence base pertaining to the management of oropharyngeal cancer and provides recommendations on management for this group of patients receiving cancer care.",

author = "H Mehanna and M Evans and M Beasley and S Chatterjee and M Dilkes and J Homer and J O'hara and M Robinson and R Shaw and P Sloan",

year = "2016",

month = may,

day = "12",

doi = "10.1017/S0022215116000505",

language = "English",

volume = "130",

pages = "S90--S96",

journal = "The Journal of laryngology and otology",

issn = "0022-2151",

publisher = "Cambridge University Press",

number = "S2",

}

TY - JOUR

T1 - Oropharyngeal cancer

T2 - United Kingdom National Multidisciplinary Guidelines

AU - Mehanna, H

AU - Evans, M

AU - Beasley, M

AU - Chatterjee, S

AU - Dilkes, M

AU - Homer, J

AU - O'hara, J

AU - Robinson, M

AU - Shaw, R

AU - Sloan, P

PY - 2016/5/12

Y1 - 2016/5/12

N2 - This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. There has been significant debate in the management of oropharyngeal cancer in the last decade, especially in light of the increased incidence, clarity on the role of the human papilloma virus in this disease and the treatment responsiveness of the human papilloma virus positive cancers. This paper discusses the evidence base pertaining to the management of oropharyngeal cancer and provides recommendations on management for this group of patients receiving cancer care.

AB - This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. There has been significant debate in the management of oropharyngeal cancer in the last decade, especially in light of the increased incidence, clarity on the role of the human papilloma virus in this disease and the treatment responsiveness of the human papilloma virus positive cancers. This paper discusses the evidence base pertaining to the management of oropharyngeal cancer and provides recommendations on management for this group of patients receiving cancer care.

U2 - 10.1017/S0022215116000505

DO - 10.1017/S0022215116000505

M3 - Article

SN - 0022-2151

VL - 130

SP - S90-S96

JO - The Journal of laryngology and otology

JF - The Journal of laryngology and otology

IS - S2

ER -

Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this